Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2003
06/04/2003CN1110301C Therapeutic preparation for inhalation
06/04/2003CN1110300C Process I
06/04/2003CN1110299C Triazazole nucleoside aerosol and its preparing method
06/04/2003CN1110298C Dermatologic preparation for external use
06/03/2003WO2003045484A2 Open-celled substrates for drug delivery
06/03/2003US6573390 Muscle relaxant, hypotensive agent, respiratory system disorders, gastrointestinal disorders, fertility, incontinence, shock, antiinflammatory agents, immunology, bone disorders, antiproliferative agents
06/03/2003US6573302 Topical carrier wherein the topical carrier comprises a member selected from the group comprising lavender oil, myristal myristate, and other preservatives including, hypericum perforatum arnica montana capric acid; and capsaicin and
06/03/2003US6573299 Method and compositions for treatment of the aging eye
06/03/2003US6573271 Following surgery or trauma or resulting in ocular diseases associated with choroidal neovascularization, such as age related macular degeneration and histoplasmosis syndrome
06/03/2003US6573264 Heteroaryl alkyl piperazine derivatives
06/03/2003US6573257 Salen-metal complexes having superoxide, catalase and/or peroxidase activity to treat or prevent diseases from cell or tissue damage
06/03/2003US6573253 Methods for the administration of amifostine and related compounds
06/03/2003US6573249 Topical wound therapeutic compositions
06/03/2003US6573241 Therapeutic agent for the suppression of snoring noises
06/03/2003US6573239 Compound comprising 15 to 26-residue peptide or peptide analogue which forms amphipathic alpha-helix in presence of lipids and exhibits specified lecithin:cholesterol acyltransferase activation activity
06/03/2003US6573238 A biodegradable microparticle by forming a coating of a viscous form of a polypeptide e.g., insulin-like growth factor, with a poly(alpha-hydroxy acid), a polyhydroxybutyric acid, a polycaprolactone, a polyorthoester or a polyanhydride
06/03/2003US6573100 DNA vectors without a selection marker gene
06/03/2003US6572906 Foods, beverages, cosmetics
06/03/2003US6572898 Electrolyte gels for maintaining hydration and rehydration
06/03/2003US6572894 Biodegradable polymer
06/03/2003US6572893 Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
06/03/2003US6572892 Solid blend of hydrophobic wax, an oil and talc
06/03/2003US6572891 Sublingual oral dosage form
06/03/2003US6572890 Drug delivery; therapy for psychological disorders
06/03/2003US6572889 Crosslinked polymer of an unsaturated acid
06/03/2003US6572888 Controlled release lipoic acid
06/03/2003US6572887 Polysaccharide material for direct compression
06/03/2003US6572886 Dextrose-based lozenges and process for their manufacture
06/03/2003US6572885 Inert pharmaceutically acceptable substrates containing an annalgesic with diameter of .1 mm-3 mm, effective blood levels for at least 24 hours
06/03/2003US6572884 Parenteral Cisplatin emulsion
06/03/2003US6572881 Delivery of polynucleotides to cells; polylactam
06/03/2003US6572880 Methods and transdermal compositions for pain relief
06/03/2003US6572879 Formulations for transdermal delivery of pergolide
06/03/2003US6572878 Method and device for treating scars
06/03/2003US6572876 Soy protein, isoflavone and plant sterol coadministered for atherosclerosis prevention
06/03/2003US6572875 Biodegradable microbicidal vaginal barrier device
06/03/2003US6572874 Vaginal delivery of bisphosphonates
06/03/2003US6572873 Sclerosing liquid for blood vessels, varicose veins and other disorders involving venous malformation; injectable foam using high volume percentages of blood dispersible gases, thus avoiding use of potentially hazardous amounts of nitrogen
06/03/2003US6572871 Pain treatment method and apparatus using heating wrap and analgesic cream
06/03/2003US6572861 Lecithin, oil in water emulsion and an amphiphilic surfactant; minimize local reactions to the vaccine
06/03/2003US6572858 Uses for anti-malarial therapeutic agents
06/03/2003US6572849 Buffered and low pH; inhbits microbial growth within
06/03/2003US6572841 Composition and method for decreasing upper respiratory airway resistance
06/03/2003US6572672 A non-stoichiometric non-equilibrium material, especially a metal or polymer
06/03/2003US6572605 Implantable device and use therefor
06/03/2003CA2462576A1 Open-celled substrates for drug delivery
06/03/2003CA2282757C Opthalmic composition
06/03/2003CA2275554C Intranasal formulations for treating sexual disorders
06/03/2003CA2137910C Use of microcapsules as contrasting agents in colour doppler sonography
06/03/2003CA2108266C Convertible microemulsion formulations
06/03/2003CA2094275C Methods and compositions for the treatment of cell proliferation disorders
05/2003
05/30/2003WO2003044187A2 Emulsion compositions
05/30/2003WO2003044080A1 Water-in-silicone emulsions
05/30/2003WO2003044076A1 Bioerodible poly(ortho esters) containing amine groups, and block copolymers containing them
05/30/2003WO2003043813A1 Microencapsulated particles and process for manufacturing same
05/30/2003WO2003043729A1 Nanocapsules and microcapsules comprising reactive polymers and method for the production thereof
05/30/2003WO2003043672A1 Preparations appropriate for cartilage tissue formation
05/30/2003WO2003043661A1 Preparation compositions containing acid-unstable physiologically acitve compounds and process for producing the same
05/30/2003WO2003043660A2 Composition for stabilizing hyaluronic acid
05/30/2003WO2003043659A1 Edible film
05/30/2003WO2003043657A1 Topical delivery of codrugs
05/30/2003WO2003043649A1 Removal promoters and inhibitor for apoptosis cells in vivo
05/30/2003WO2003043641A1 New pharmaceutical combinations prepared with alginates and biphosphonates in order to prevent gastroesophageal reflux during use of oral biphoshonates
05/30/2003WO2003043638A1 Coated particulate cefuroxime axetil compositions
05/30/2003WO2003043633A1 Use of an ascomycin for the treatment of blepharitis
05/30/2003WO2003043630A1 Solid pharmaceutical composition comprising 4-cyano-trifluoro-3-(4-fluorophenyl sulphonyl)-2-hydroxy-2-methylpropiono- m toluidide, pvp, an anti-oestrogen and/or an aromatase inhibitor
05/30/2003WO2003043627A1 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma
05/30/2003WO2003043621A1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes
05/30/2003WO2003043612A1 Micronized film-forming powder comprising an active substance
05/30/2003WO2003043611A1 Device containing microfibers for controlled release of substances
05/30/2003WO2003043610A2 A process for manufacture of a sustained release composition containing microbe
05/30/2003WO2003043609A1 Non-gelatinous capsule film compositions and capsules using the same
05/30/2003WO2003043608A1 Process for the preparation of tablets comprising s-adenosylmethionine
05/30/2003WO2003043607A1 A pharmaceutical composition for controlled release of a beta-lactam antibiotic
05/30/2003WO2003043606A1 Pharmaceutical formulation comprising bicalutamide
05/30/2003WO2003043605A1 Method for preparing microparticles free of toxic solvent, resulting microparticles and pharmaceutical compositions
05/30/2003WO2003043604A1 Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid
05/30/2003WO2003043603A1 Particulate compositions for improving solubility of poorly soluble agents
05/30/2003WO2003043602A1 Solid dispersions containing substituted cyclodextrin and insoluble drug and their preparations
05/30/2003WO2003043601A2 Modular systems for the controlled release of a substance with space and time control
05/30/2003WO2003043600A1 Water-soluble non-effervescent pharmaceutical compositions comprising non-steroidal anti-inflammatory drugs
05/30/2003WO2003043586A2 Compositions for sustained action product delivery
05/30/2003WO2003043585A2 Improved particulate compositions for pulmonary delivery
05/30/2003WO2003043584A2 Engineered liposomal particles containing core-loaded pro-drugs for the controlled release of camptothecins
05/30/2003WO2003043574A2 Pharmaceutical compositions in particulate form
05/30/2003WO2003043548A1 Visco dye
05/30/2003WO2003043517A2 Dentifrice compositions
05/30/2003WO2003028697A3 Liposome loading with metal ions
05/30/2003WO2003015817A3 Oral immunoglobulin treatment for inflammatory bowel disease
05/30/2003WO2003013478A3 Method of encapsulating an active substance
05/30/2003WO2003007994A3 Thyroid therapeutic agents containing partial glycerides and dextrin
05/30/2003WO2003005952A3 Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres
05/30/2003WO2003003976A3 Compositions for removing human cerumen
05/30/2003WO2002100890A3 Respiratory syncytial virus
05/30/2003WO2002078718A3 Compositions, methods and apparatuses for singlet oxygen delivery
05/30/2003WO2002076499A3 Combination treatment of pancreatic cancer
05/30/2003WO2002076485A3 Vaccine for modulating between t1 and t2 immune responses
05/30/2003WO2002076379A3 Medicated tattoos
05/30/2003WO2002064132A3 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
05/30/2003WO2002060384A3 Pharmaceutical formulation
1 ... 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 ... 2991